[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369316-105":59,"doc-detail-369316-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","germline-whole-exome-sequencing-in-non-smoker-lung-cancer-patients-reveals-pathogenic-variants-in-lung-cancer-driver-genes","Germline Whole-Exome Sequencing in Non-Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes","","Approximately 10%–15% of lung cancers occur in non-smokers, where established causes are unclear despite evidence that family history increases risk. Whole-exome sequencing of peripheral blood from 75 pre-lobectomy patients was used to search for germline alterations with strong clinical relevance. Pathogenic or likely pathogenic variants were found across 31 genes, including cancer-predisposing genes and multiple lung cancer driver genes enriched for DNA repair and metabolic mechanisms. Results support germline molecular testing for non-smoker patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/germline-whole-exome-sequencing-in-non-smoker-lung-cancer-patients-reveals-pathogenic-variants-in-lung-cancer-driver-genes/369316/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/germline-whole-exome-sequencing-in-non-smoker-lung-cancer-patients-reveals-pathogenic-variants-in-lung-cancer-driver-genes/369316.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How common are lung cancers in non-smokers, and why is host genetics suspected?","Question",{"text":112,"@type":113},"About 10%–15% of lung cancers arise in non-smokers. Although clear aetiological factors are lacking, non-smokers with a family history show increased risk, indicating a role for host genetic factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What method was used to detect germline alterations in the study?",{"text":117,"@type":113},"Whole-exome sequencing was performed on genomic DNA extracted from peripheral blood of 75 patients recruited before lung lobectomy.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about pathogenic germline variants and which genes were emphasized?",{"text":121,"@type":113},"Thirty-three pathogenic or likely pathogenic variants across 31 genes were identified, including variants in cancer-predisposing genes and lung cancer driver genes. Many implicated genes related to DNA repair mechanisms and metabolic diseases, supporting germline molecular testing for non-smoker patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369316,1790229936,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Genes, Chromosomes and Cancer  \nRESEARCH ARTICLE  OPEN ACCESS   \nGermline Whole-Exome Sequencing in Non-Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes  \nGiovanni Carapezza1 | Simone Paolo Minardi1  | Sara Noci2 | Giulia Pintarelli2 | Susanna Zanutto2 | Matteo Incarbone3 | Davide Tosi4 | Tommaso Antonio Dragani2 | Francesca Colombo5 | Marco Alessandro Pierotti1 | Manuela Gariboldi2   \n1Cogentech S.R.L.Benefit C. With Only Stakeholder Fondazione IFOM ETS, Milano, Italy | 2Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy | 3Ospedale San Giuseppe, IRCCS Multimedica, Milano, Italy | 4Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy | 5National Research Council, Institute for Biomedical Technologies, Segrate, Italy  \nCorrespondence: Manuela Gariboldi (manuela.gariboldi@istitutotumori.mi.it)  \nReceived: 23 December 2024 | Revised: 27 February 2025 | Accepted: 28 February 2025  \nFunding: This research was supported by the Associazione Italiana Ricerca sul Cancro (AIRC 2017 IG 20226 to T.A.D.) and by Ministry of Health “Ricerca Corrente”.  \nKeywords: DNA repair-related genes | genetic risk factors | germline molecular testing | non-smoker lung cancer | pathogenic germline variants  \nABSTRACT  \nApproximately 10%–15% of all lung cancers arise in non-smokers. Although there are no established aetiological factors, nonsmokers with a family history of cancer have an increased risk of lung cancer, implying host genetic factors in lung cancer susceptibility. We sought to identify, in a cohort of 75 patients recruited before lung lobectomy, germline alterations with a strong association with lung cancer. Whole-exome sequencing was performed on genomic DNA from peripheral blood. Six resources were used to select pathogenic germline variants with strong clinical significance. In total, 33 pathogenic or likely pathogenic variants in 31 genes were identified. Of these, 13 were located in cancer-predisposing genes (nine were lung cancer drivers), most of which were involved in DNA repair mechanisms and diseases of metabolism. Among DNA repair-related genes, BRCA1 and BRCA2, and ATM have also been identified in other studies on non-smokers. Our results strongly support the hypothesis that a number of non-smoker lung cancer patients carry germline variants in cancer-predisposing genes, suggesting that lung cancer patients, particularly non-smokers, should be considered for germline molecular testing.  \n1 | Introduction  \nLung cancer is the most common cancer and the leading cause of cancer-related mortality worldwide [1] . It is generally regarded as a smoker's cancer; however, about 10% to 15% of  \nlung cancers arise in non-smokers. The rate of lung cancer in non-smokers is increasing [2] and tends to be more common in females [3] . Most of the non-smokers are asymptomatic or have non-specific features, and cancer is diagnosed during cardiological follow-up or surveillance imaging for other previous  \n\n| Abbreviations: ACADVL, acyl-CoA dehydrogenase very long chain; ADA, adenosine deaminase; ATM, ATM serine/threonine kinase; BRAF, B-Raf proto-oncogene, serine/threonine kinase; BRCA1, BReast CAncer gene 1 DNA repair associated; BRCA2, BReast CAncer gene 2 DNA repair associated; BTD, biotinidase; COL1A1, collagen type I alpha 1 chain; CPG, cancer predisposing gene; DNMT3A, DNA methyltransferase 3 alpha; FH, fumarate hydratase (FH); GAA, alpha glucosidase; GALNS, galactosamine (N-acetyl)-6-sulfatase; GJB2, gap junction protein beta 2; GYG1, glycogenin 1; HERC2, HECT and RLD domain-containing E3 ubiquitin protein ligase 2; IVD, isovaleryl-CoA dehydrogenase; KEAP1, kelch like ECH associated protein 1; LCDG, lung cancer driver gene; MLH1, mutL homolog 1; MMAB, metabolism of cobalamin associated with B; MUTYH, mutY DNA glycosylase; NSCLC, Non-small-cell lung cancer; NUP93 , nucleoporin 93; PEX1, peroxisomal biogenesis factor 1; PGV, pathogenic germline variants; POLG, DNA polymerase ","cbCaiiKZ9GC5D8Sw","https://ap.wps.com/l/cbCaiiKZ9GC5D8Sw","pdf",271967,"English","# Introduction\n# Study Design and Cohort\n## Whole-Exome Sequencing and Variant Selection\n## Pathogenic Germline Variants Identified\n## DNA Repair and Cancer Predisposing Genes\n# Abbreviations","[{\"question\":\"How common are lung cancers in non-smokers, and why is host genetics suspected?\",\"answer\":\"About 10%–15% of lung cancers arise in non-smokers. Although clear aetiological factors are lacking, non-smokers with a family history show increased risk, indicating a role for host genetic factors.\"},{\"question\":\"What method was used to detect germline alterations in the study?\",\"answer\":\"Whole-exome sequencing was performed on genomic DNA extracted from peripheral blood of 75 patients recruited before lung lobectomy.\"},{\"question\":\"What did the study find about pathogenic germline variants and which genes were emphasized?\",\"answer\":\"Thirty-three pathogenic or likely pathogenic variants across 31 genes were identified, including variants in cancer-predisposing genes and lung cancer driver genes. Many implicated genes related to DNA repair mechanisms and metabolic diseases, supporting germline molecular testing for non-smoker patients.\"}]","Germline Whole-Exome Sequencing in Non-Smoker Lung Cancer Patients Reveals Pathogenic Variants in Lung Cancer Driver Genes | PDF",1790181932,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ee628f4a8f7b5ae9ecd4cfb4109c4b2.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9054f221ecbee013c42037cdb0bff814.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea94fb8ea754ef2db888c89e4310edc5.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b78139471bdce07fd508ce3eafecada.webp",980,1287]